• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颌骨药物性骨坏死(MRONJ)预防与管理策略的综合综述

Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).

作者信息

Baghalipour Nasimeh, Moztarzadeh Omid, Samar Walla, Gencur Jiri, Volf Vaclav, Hauer Lukas

出版信息

Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.

DOI:10.3290/j.ohpd.c_2169
PMID:40762678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12327072/
Abstract

PURPOSE

To assess and classify the strategies employed in various dental specialities for the prevention and management of medication-related osteonecrosis of the jaw (MRONJ).

MATERIALS AND METHODS

A comprehensive literature review was conducted, acquiring studies sourced from Google Scholar and PubMed. The emphasis was on studies published in recent years, focusing on successful MRONJ prevention techniques across various dental specialties.

RESULTS

Four types of prevention were identified. Primary prevention strategies include optimizing oral hygiene, managing dental caries, and extraction of hopeless teeth in patients before starting antiresorptive or antiangiogenic medications, to reduce MRONJ risk. Secondary prevention techniques involve tailored approaches during procedures employed during different dental specialties aimed at reducing complications in susceptible patients. Tertiary prevention focuses on managing established MRONJ, aiming to relieve symptoms and prevent further deterioration. Quaternary prevention seeks to limit overmedicalisation and reduce risks associated with medications that contribute to MRONJ development.

CONCLUSION

Primary prevention remains the prevention of choice in terms of minimising the possible incidence of MRONJ, while secondary and tertiary prevention strategies are vital for managing risks and improving outcomes in susceptible patients. Quaternary prevention requires more research focusing on reducing the incidence of underlying conditions such as osteoporosis and cancer, which are associated with MRONJ development.

摘要

目的

评估和分类不同牙科专业用于预防和管理药物相关性颌骨坏死(MRONJ)所采用的策略。

材料与方法

进行了全面的文献综述,获取了来自谷歌学术和PubMed的研究。重点是近年来发表的研究,聚焦于不同牙科专业成功的MRONJ预防技术。

结果

确定了四种预防类型。一级预防策略包括在开始抗吸收或抗血管生成药物治疗前,优化口腔卫生、治疗龋齿以及拔除患者的无保留价值牙齿,以降低MRONJ风险。二级预防技术涉及在不同牙科专业的操作过程中采用针对性方法,旨在减少易感患者的并发症。三级预防侧重于管理已确诊的MRONJ,旨在缓解症状并防止病情进一步恶化。四级预防旨在限制过度医疗,并降低与导致MRONJ发生的药物相关的风险。

结论

就将MRONJ的可能发生率降至最低而言,一级预防仍是首选的预防措施,而二级和三级预防策略对于管理易感患者的风险和改善预后至关重要。四级预防需要更多研究聚焦于降低与MRONJ发生相关的潜在疾病如骨质疏松症和癌症的发病率。

相似文献

1
Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).颌骨药物性骨坏死(MRONJ)预防与管理策略的综合综述
Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.
2
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
3
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
4
How does medication-related osteonecrosis of the jaw (MRONJ) influence the health-related quality of life after surgery?药物相关性颌骨坏死(MRONJ)如何影响术后与健康相关的生活质量?
BMC Oral Health. 2025 Jun 21;25(1):951. doi: 10.1186/s12903-025-06171-3.
5
The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature.人羊膜(hAM)在药物相关性颌骨坏死(MRONJ)治疗策略中的应用:文献的系统评价和荟萃分析。
Medicina (Kaunas). 2023 May 17;59(5):968. doi: 10.3390/medicina59050968.
6
Awareness and Attitude Towards MRONJ Among Physicians Prescribing Antiresorptive Drugs: A Cross-Sectional Study.开具抗骨吸收药物的医生对药物相关颌骨坏死的认知与态度:一项横断面研究
BMC Oral Health. 2025 Jul 2;25(1):985. doi: 10.1186/s12903-025-06490-5.
7
Introducing equivalent and threshold doses in the assessment of medication-related osteonecrosis of the jaw risk: insights from a descriptive study in Iran.在颌骨药物相关性骨坏死风险评估中引入等效剂量和阈剂量:来自伊朗一项描述性研究的见解
Support Care Cancer. 2025 Jul 6;33(7):661. doi: 10.1007/s00520-025-09649-6.
8
Medication-related osteonecrosis of the jaw, a risk to reassess in osteoporotic patients.药物相关性颌骨坏死,骨质疏松患者需重新评估的风险。
J Stomatol Oral Maxillofac Surg. 2023 Feb;124(1S):101316. doi: 10.1016/j.jormas.2022.10.015. Epub 2022 Oct 21.
9
Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis.拔牙后与药物相关的颌骨坏死的发生和风险指标:系统评价和荟萃分析。
J Clin Periodontol. 2015 Oct;42(10):922-32. doi: 10.1111/jcpe.12455. Epub 2015 Nov 3.
10
[Drug-related jaw osteonecrosis: a 6-year retrospective study from two centers in Argentina].[药物相关性颌骨骨坏死:来自阿根廷两个中心的6年回顾性研究]
Rev Fac Cien Med Univ Nac Cordoba. 2025 Jun 26;82(2):318-342. doi: 10.31053/1853.0605.v82.n2.46061.

本文引用的文献

1
Secukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritis.司库奇尤单抗导致一名诊断为银屑病和类风湿关节炎患者的药物相关性颌骨坏死。
Psoriasis (Auckl). 2024 Sep 23;14:115-120. doi: 10.2147/PTT.S490982. eCollection 2024.
2
Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series.药物相关性颌骨坏死:病例报告与病例系列的系统评价
Diseases. 2024 Sep 9;12(9):205. doi: 10.3390/diseases12090205.
3
Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ).意大利关于药物相关性颌骨坏死 (MRONJ) 的立场文件 (SIPMO-SICMF)。
Oral Dis. 2024 Sep;30(6):3679-3709. doi: 10.1111/odi.14887. Epub 2024 Feb 5.
4
Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement. navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement.
Acta Chir Belg. 2024 Feb;124(1):1-11. doi: 10.1080/00015458.2023.2291295. Epub 2024 Jan 24.
5
Efficacy of Chlorhexidine after Oral Surgery Procedures on Wound Healing: Systematic Review and Meta-Analysis.口腔外科手术后洗必泰对伤口愈合的疗效:系统评价与荟萃分析
Antibiotics (Basel). 2023 Oct 20;12(10):1552. doi: 10.3390/antibiotics12101552.
6
Pathophysiology of Medication-Related Osteonecrosis of the Jaw-A Minireview.颌骨药物相关性骨坏死的病理生理学——一篇综述
JBMR Plus. 2023 Jun 22;7(8):e10785. doi: 10.1002/jbm4.10785. eCollection 2023 Aug.
7
Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.应用富血小板纤维蛋白预防和治疗药物性下颌骨坏死:一项临床可行性研究。
Clin Exp Dent Res. 2023 Oct;9(5):791-798. doi: 10.1002/cre2.775. Epub 2023 Aug 21.
8
Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP).抗吸收治疗在患有牙周炎的骨代谢患者中的应用。意大利矫形外科和创伤学会(SIOT)与意大利牙周病学和种植学会(SIdP)的联合立场文件。
J Orthop Traumatol. 2023 Jul 15;24(1):36. doi: 10.1186/s10195-023-00713-7.
9
Evaluation of Preventive Role of Systemically Applied Erythropoietin after Tooth Extraction in a Bisphosphonate-Induced MRONJ Model.评价系统性应用促红细胞生成素在双膦酸盐诱导的 MRONJ 模型拔牙后预防作用。
Medicina (Kaunas). 2023 May 31;59(6):1059. doi: 10.3390/medicina59061059.
10
Potential Relationship between Poor Oral Hygiene and MRONJ: An Observational Retrospective Study.口腔卫生不良与 MRONJ 之间的潜在关系:一项观察性回顾性研究。
Int J Environ Res Public Health. 2023 Apr 5;20(7):5402. doi: 10.3390/ijerph20075402.